MDS Proteomics and Zyomyx collaborate in protein pathway studies

MDS Proteomics, a majority owned subsidiary of MDS (MDZ; TSE:MDS), will work with Zyomyx (Hayward, Calif.) to identify and analyze protein pathways. Zyomyx will contribute its protein biochip technolo...